Pioglitazone Hydrochloride Patent Expiration

Pioglitazone Hydrochloride is Used for managing and improving glycemic control in patients with type 2 diabetes. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Actos on Jul 15, 1999. 15 different companies have introduced drugs containing Pioglitazone Hydrochloride.


Pioglitazone Hydrochloride Patents

Given below is the list of patents protecting Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Actos US6303640 Pharmaceutical composition Aug 09, 2016

(Expired)

Takeda Pharms Usa
Actos US5965584 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6150383 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6150384 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6166042 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6166043 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6172090 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6211205 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6271243 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6329404 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa



Pioglitazone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pioglitazone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Pioglitazone Hydrochloride. The first generic version for Pioglitazone Hydrochloride was by Norvium Bioscience Llc and was approved on Aug 17, 2012. And the latest generic version is by Corepharma Llc and was approved on Jan 22, 2021.

Given below is the list of companies who have filed for Pioglitazone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.